387 related articles for article (PubMed ID: 34290570)
21. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract][Full Text] [Related]
22. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
23. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Li A; Hou S; Chen J; Jiang Y
Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
[TBL] [Abstract][Full Text] [Related]
25. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival.
Wang L; Wu Z; Xu C; Ye H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18119-18134. PubMed ID: 38007403
[TBL] [Abstract][Full Text] [Related]
28. Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma.
Wang C; Shi M; Zhang L; Ji J; Xie R; Wu C; Guo X; Yang Y; Zhou W; Peng C; Zhang H; Yuan F; Zhang J
Cancer Immunol Immunother; 2022 Feb; 71(2):491-504. PubMed ID: 34255132
[TBL] [Abstract][Full Text] [Related]
29. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
30. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
Gu X; Zhang Q; Wu X; Fan Y; Qian J
World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
[TBL] [Abstract][Full Text] [Related]
31. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
32. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
33. CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.
Liu K; Li L; Han G
Front Endocrinol (Lausanne); 2023; 14():1226547. PubMed ID: 38333724
[TBL] [Abstract][Full Text] [Related]
34. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
[TBL] [Abstract][Full Text] [Related]
35. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.
Liu X; Chen B; Chen J; Sun S
BMC Cancer; 2021 Mar; 21(1):335. PubMed ID: 33789615
[TBL] [Abstract][Full Text] [Related]
36. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
Wang C; Wang Z; Zhao Y; Jia R
BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma.
Xu D; Qin R; Li M; Shen J; Mao Y; Tang K; Zhang A; Wang D; Shi Y
Medicine (Baltimore); 2022 Nov; 101(46):e29683. PubMed ID: 36401386
[TBL] [Abstract][Full Text] [Related]
39. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M
Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527
[TBL] [Abstract][Full Text] [Related]
40. Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients.
Li N; Chen J; Yu W; Huang X
BMC Gastroenterol; 2023 Sep; 23(1):312. PubMed ID: 37710166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]